HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fotios Dimitriadis Selected Research

Prostatic Hyperplasia (Benign Prostatic Hyperplasia)

4/2013Characterization of silodosin and naftopidil in the treatment of bladder dysfunction in the spontaneously hypertensive rat.
10/2010Muscarinic receptors and their mRNAs in type 2 Goto-Kakizaki diabetic rat prostate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fotios Dimitriadis Research Topics

Disease

7Male Infertility (Male Sterility)
07/2022 - 01/2021
7Hypertension (High Blood Pressure)
03/2014 - 06/2012
5Reperfusion Injury
01/2016 - 03/2010
4Infertility (Sterility)
07/2021 - 01/2016
4Erectile Dysfunction
06/2021 - 10/2012
2Penile Induration (Peyronie's Disease)
09/2022 - 06/2021
2Type 2 Diabetes Mellitus (MODY)
03/2015 - 10/2010
2Lower Urinary Tract Symptoms
03/2014 - 10/2010
2Overactive Urinary Bladder (Overactive Bladder)
04/2013 - 06/2012
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
04/2013 - 10/2010
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2012 - 06/2011
2Urinary Retention
09/2012 - 06/2010
2Ischemia
06/2012 - 05/2012
1Varicocele
07/2021
1Urge Urinary Incontinence (Urge Incontinence)
01/2021
1Urinary Tract Infections (Urinary Tract Infection)
08/2019
1Multiple Sclerosis
12/2017
1Hypoxia (Hypoxemia)
01/2016
1Spermatic Cord Torsion (Testicular Torsion)
01/2016
1Nocturia
04/2013
1Diabetes Mellitus
10/2012
1Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
07/2012
1Heart Failure
05/2011

Drug/Important Bio-Agent (IBA)

6AntioxidantsIBA
09/2021 - 10/2012
4Reactive Oxygen Species (Oxygen Radicals)IBA
09/2021 - 10/2012
4Adenosine Triphosphate (ATP)IBA
09/2012 - 06/2010
3Pharmaceutical PreparationsIBA
01/2021 - 01/2021
3EdaravoneIBA
10/2012 - 03/2010
2mirabegronIBA
01/2021 - 12/2017
2olmesartanIBA
03/2014 - 01/2014
2silodosinFDA Link
04/2013 - 07/2012
2rho-Associated KinasesIBA
10/2012 - 09/2012
2KATP ChannelsIBA
09/2012 - 06/2010
2PotassiumIBA
09/2012 - 05/2011
2Nicorandil (SG 75)IBA
06/2012 - 05/2011
2Free Radical ScavengersIBA
06/2011 - 03/2010
1AntibodiesIBA
07/2022
1Biomarkers (Surrogate Marker)IBA
09/2021
1Phosphodiesterase 5 InhibitorsIBA
01/2021
1SolutionsIBA
01/2021
1Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
12/2017
1CytokinesIBA
01/2016
1Testosterone (Sustanon)FDA Link
03/2015
1Angiotensin IIIBA
03/2014
1Nifedipine (Adalat)FDA LinkGeneric
01/2014
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2014
1Angiotensin Receptor AntagonistsIBA
01/2014
1naftopidilIBA
04/2013
1TaurineFDA Link
10/2012
1hydroxyfasudilIBA
10/2012
1fasudil (AT 877)IBA
09/2012
1Adrenergic Receptors (Adrenergic Receptor)IBA
07/2012
1Cromakalim (Levcromakalim)IBA
05/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2011
1Nitric Oxide DonorsIBA
05/2011
1sivelestatIBA
01/2011
1Secretory Proteinase Inhibitory ProteinsIBA
01/2011
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
10/2010

Therapy/Procedure

2Therapeutics
09/2022 - 11/2017
1Conservative Treatment
09/2022
1Penile Implantation
06/2021
1Urinary Diversion (Ileal Conduit)
08/2019
1Cystectomy
08/2019
1Antibiotic Prophylaxis
08/2019
1Extracorporeal Shockwave Therapy
01/2019
1Ischemic Postconditioning
01/2016